These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34950596)

  • 1. A Novel miR-98 Negatively Regulates the Resistance of Endometrial Cancer Cells to Paclitaxel by Suppressing ABCC10/MRP-7.
    Huang W; Zhang J; Dong B; Chen H; Shao L; Li X
    Front Oncol; 2021; 11():809410. PubMed ID: 34950596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Non-Coding RNA TMPO-AS1 Promotes GLUT1-Mediated Glycolysis and Paclitaxel Resistance in Endometrial Cancer Cells by Interacting With miR-140 and miR-143.
    Dong P; Wang F; Taheri M; Xiong Y; Ihira K; Kobayashi N; Konno Y; Yue J; Watari H
    Front Oncol; 2022; 12():912935. PubMed ID: 35712514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA NEAT1 promotes endometrial cancer cell proliferation, migration and invasion by regulating the miR-144-3p/EZH2 axis.
    Wang W; Ge L; Xu XJ; Yang T; Yuan Y; Ma XL; Zhang XH
    Radiol Oncol; 2019 Nov; 53(4):434-442. PubMed ID: 31747378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-218 inhibits HMGB1-mediated autophagy in endometrial carcinoma cells during chemotherapy.
    Ran X; Yang J; Liu C; Zhou P; Xiao L; Zhang K
    Int J Clin Exp Pathol; 2015; 8(6):6617-26. PubMed ID: 26261543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Non-coding RNA CDKN2B Antisense RNA 1 Gene Contributes to Paclitaxel Resistance in Endometrial Carcinoma.
    Shang C; Ao CN; Cheong CC; Meng L
    Front Oncol; 2019; 9():27. PubMed ID: 30761271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer.
    Chang L; Hu Z; Zhou Z; Zhang H
    Cell Physiol Biochem; 2018; 48(1):16-28. PubMed ID: 30001527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lncRNA NEAT1 facilitates cell growth and invasion via the miR-211/HMGA2 axis in breast cancer.
    Li X; Wang S; Li Z; Long X; Guo Z; Zhang G; Zu J; Chen Y; Wen L
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):346-353. PubMed ID: 28720546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the potential theranostic role of KDM5B/miR-29c signaling axis in paclitaxel resistant endometrial carcinoma.
    Li L; Shou H; Wang Q; Liu S
    Gene; 2019 Apr; 694():76-82. PubMed ID: 30658067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP).
    Vanhoefer U; Cao S; Harstrick A; Seeber S; Rustum YM
    Ann Oncol; 1997 Dec; 8(12):1221-8. PubMed ID: 9496387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-297 modulates multidrug resistance in human colorectal carcinoma by down-regulating MRP-2.
    Xu K; Liang X; Shen K; Cui D; Zheng Y; Xu J; Fan Z; Qiu Y; Li Q; Ni L; Liu J
    Biochem J; 2012 Sep; 446(2):291-300. PubMed ID: 22676135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of NEAT1/miR-214-3p on the growth, migration and invasion of endometrial carcinoma cells.
    Wang J; Zhao X; Guo Z; Ma X; Song Y; Guo Y
    Arch Gynecol Obstet; 2017 Jun; 295(6):1469-1475. PubMed ID: 28447190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells.
    Zheng H; Wang JJ; Yang XR; Yu YL
    World J Gastroenterol; 2020 Feb; 26(5):499-513. PubMed ID: 32089626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of the oncogene lncRNA NEAT1 restores the availability of
    Hu Y; Yang Q; Wang L; Wang S; Sun F; Xu D; Jiang J
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29654165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA UCA1 promotes the progression of paclitaxel resistance in ovarian cancer by regulating the miR-654-5p/SIK2 axis.
    Li ZY; Wang XL; Dang Y; Zhu XZ; Zhang YH; Cai BX; Zheng L
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):591-603. PubMed ID: 32016960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of miR-335-3p, targeted by NEAT1 and MALAT1 long non-coding RNAs, is associated with poor prognosis in childhood acute lymphoblastic leukemia.
    Pouyanrad S; Rahgozar S; Ghodousi ES
    Gene; 2019 Apr; 692():35-43. PubMed ID: 30639603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long non-coding RNA NEAT1 regulates epithelial to mesenchymal transition and radioresistance in through miR-204/ZEB1 axis in nasopharyngeal carcinoma.
    Lu Y; Li T; Wei G; Liu L; Chen Q; Xu L; Zhang K; Zeng D; Liao R
    Tumour Biol; 2016 Sep; 37(9):11733-11741. PubMed ID: 27020592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.
    Dong P; Ihira K; Xiong Y; Watari H; Hanley SJ; Yamada T; Hosaka M; Kudo M; Yue J; Sakuragi N
    Oncotarget; 2016 Apr; 7(15):20260-70. PubMed ID: 26934121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling.
    Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X
    IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer.
    Li Y; Zhang L; Dong Z; Xu H; Yan L; Wang W; Yang Q; Chen C
    Pathol Res Pract; 2021 Apr; 220():153405. PubMed ID: 33756128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA NEAT1 regulates permeability of the blood-tumor barrier via miR-181d-5p-mediated expression changes in ZO-1, occludin, and claudin-5.
    Guo J; Cai H; Zheng J; Liu X; Liu Y; Ma J; Que Z; Gong W; Gao Y; Tao W; Xue Y
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2240-2254. PubMed ID: 28185956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.